{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:41:00Z","timestamp":1791909660509,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1500201"],"award-info":[{"award-number":["2021YFA1500201"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404430"],"award-info":[{"award-number":["82404430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2023B1111050008"],"award-info":[{"award-number":["2023B1111050008"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005893","name":"China Academy of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["ZZ13-035-02"],"award-info":[{"award-number":["ZZ13-035-02"]}],"id":[{"id":"10.13039\/501100005893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","award":["JCYJ20240813094404007"],"award-info":[{"award-number":["JCYJ20240813094404007"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012449","name":"Southern University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118642","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:54:07Z","timestamp":1770364447000},"page":"118642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Rational design of dual PB2\/JAK2 inhibitors achieving balanced antiviral and host-directed immunomodulatory effects"],"prefix":"10.1016","volume":"307","author":[{"given":"Yujian","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhao","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanmei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peisen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinshan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xumu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5738-3511","authenticated-orcid":false,"given":"Qifan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118642_bib1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41577-024-01029-1","article-title":"Defining the balance between optimal immunity and immunopathology in influenza virus infection","volume":"24","author":"Nguyen","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.118642_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0144-2024","article-title":"Influenza vaccine outcomes: a meta-analysis revealing morbidity benefits amid low infection prevention","volume":"34","author":"Presa","year":"2025","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ejmech.2026.118642_bib3","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ajpath.2024.06.004","article-title":"Influenza, fluenza, SARS-CoV-2, and their impact on chronic lung diseases and fibrosis exploring therapeutic options","volume":"194","author":"Soni","year":"2024","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2026.118642_bib4","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3390\/v15112198","article-title":"Transcriptomic profiling of influenza A virus-infected mouse lung at recovery stage using RNA sequencing","volume":"15","author":"Al-Shalan","year":"2023","journal-title":"VIRUSES-BASEL"},{"key":"10.1016\/j.ejmech.2026.118642_bib5","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1080\/21505594.2021.1939608","article-title":"Too young to die? How aging affects cellular innate immune responses to influenza virus and disease severity","volume":"12","author":"Harpur","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.ejmech.2026.118642_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/v10020076","article-title":"RNA dependent RNA polymerases: insights from structure, function and evolution","volume":"10","author":"Venkataraman","year":"2018","journal-title":"VIRUSES-BASEL"},{"key":"10.1016\/j.ejmech.2026.118642_bib7","doi-asserted-by":"crossref","first-page":"E4005","DOI":"10.1073\/pnas.1602591113","article-title":"Structural basis of viral RNA-dependent RNA polymerase catalysis and translocation","volume":"113","author":"Shu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2026.118642_bib8","doi-asserted-by":"crossref","first-page":"13475","DOI":"10.1128\/JVI.02295-12","article-title":"A small-RNA enhancer of viral polymerase activity","volume":"86","author":"Perez","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.118642_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/microorganisms12030630","article-title":"Exploring viral-host protein interactions as antiviral therapies: a computational perspective","volume":"12","author":"Idrees","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejmech.2026.118642_bib10","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1021\/acs.jmedchem.3c01543","article-title":"Antiviral protein-protein interaction inhibitors","volume":"67","author":"Markovic","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118642_bib11","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.3390\/ijms24087092","article-title":"HSV-1 glycoprotein D and its surface receptors: evaluation of protein-protein interaction and targeting by triazole-based compounds through in silico approaches","volume":"24","author":"Bivacqua","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118642_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2022.898035","article-title":"Developing small-molecule inhibitors of protein-protein interactions involved in viral entry as potential antivirals for COVID-19","volume":"2","author":"Buchwald","year":"2022","journal-title":"FRONTIERS IN DRUG DISCOVERY"},{"key":"10.1016\/j.ejmech.2026.118642_bib13","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1074\/jbc.C800224200","article-title":"Structural basis of the influenza A virus RNA polymerase PB2 RNA-binding domain containing the pathogenicity-determinant lysine 627 residue","volume":"284","author":"Kuzuhara","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118642_bib14","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1128\/JVI.00879-10","article-title":"The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon","volume":"84","author":"Graef","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.118642_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4155\/fmc-2021-0259","article-title":"Protein-protein interactions by influenza polymerase subunits as drug targets","volume":"14","author":"Felicetti","year":"2022","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118642_bib16","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1021\/jm5007275","article-title":"Discovery of a novel, first-in-Class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2","volume":"57","author":"Clark","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118642_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/13596535231174273","article-title":"Genotypic and phenotypic characterization of influenza A viral variants in study participants treated with pimodivir in the phase 2b TOPAZ study","volume":"28","author":"Vingerhoets","year":"2023","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejmech.2026.118642_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/jiy547","article-title":"Phase 2b study of pimodivir (JNJ-63623872) as monotherapy or in combination with oseltamivir for treatment of acute uncomplicated seasonal influenza A: TOPAZ trial","volume":"219","author":"Finberg","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118642_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3851\/IMP3212","article-title":"Pimodivir treatment in adult volunteers experimentally inoculated with live influenza virus: a phase IIa, randomized, double-blind, placebo-controlled study","volume":"23","author":"Trevejo","year":"2018","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejmech.2026.118642_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/ph16030365","article-title":"Preclinical study of ZSP1273, a potent antiviral inhibitor of cap binding to the PB2 subunit of influenza A polymerase","volume":"16","author":"Chen","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.118642_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(23)00743-0","article-title":"Safety and efficacy of onradivir in adults with acute uncomplicated influenza A infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118642_bib22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: immunopathology in COVID-19","volume":"72","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejmech.2026.118642_bib23","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.118642_bib24","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2174\/1381612823666170316123736","article-title":"Cytokines induced during influenza virus infection","volume":"23","author":"Betakova","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2026.118642_bib25","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.3390\/ijms24087299","article-title":"PGE2 produced by exogenous MSCs promotes immunoregulation in ARDS induced by highly pathogenic influenza A through activation of the Wnt-\u03b2-Catenin signaling pathway","volume":"24","author":"Yudhawati","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118642_bib26","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0264-410X(00)00275-9","article-title":"Inflammatory responses in influenza A virus infection","volume":"19","author":"Julkunen","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2026.118642_bib27","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3389\/fimmu.2017.01758","article-title":"Interplay between Janus kinase\/signal transducer and activator of transcription signaling activated by type I interferons and viral antagonism","volume":"8","author":"Nan","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.118642_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1385473","article-title":"Interleukin 27, like interferons, activates JAK-STAT signaling and promotes pro-inflammatory and antiviral states that interfere with dengue and chikungunya viruses replication in human macrophages","volume":"15","author":"Valdes-Lopez","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.118642_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.tim.2017.01.001","article-title":"Transcriptional regulation of antiviral interferon-stimulated genes","volume":"25","author":"Wang","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2026.118642_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.118642_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.abn8933","article-title":"Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation","volume":"376","author":"Glassman","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118642_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41375-025-02569-8","article-title":"Malignant JAK-signaling: at the interface of inflammation and malignant transformation","volume":"39","author":"Perner","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2026.118642_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112155","article-title":"Janus kinases (JAKs): the efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders","volume":"192","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118642_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13045-021-01214-y","article-title":"STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer","volume":"14","author":"Awasthi","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2026.118642_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.coi.2022.01.001","article-title":"Mechanisms encoding STAT functional diversity for context-specific inflammatory responses","volume":"74","author":"Myers","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejmech.2026.118642_bib36","article-title":"Screening and identification of host signaling pathways for alleviating influenza-induced production of pro-inflammatory cytokines, IP-10, IL-8, and MCP-1, using a U937 cell-based influenza model","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118642_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01350-23","article-title":"A panel of janus kinase inhibitors identified with anti-inflammatory effects protect mice from lethal influenza virus infection","volume":"68","author":"Yu","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118642_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/jpet.114.221176","article-title":"VX-509 (Decernotinib) is a potent and selective Janus kinase 3 inhibitor that attenuates inflammation in animal models of autoimmune disease","volume":"353","author":"Mahajan","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.118642_bib39","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1021\/acs.jmedchem.5b00301","article-title":"Discovery of VX-509 (decernotinib): a potent and selective Janus kinase 3 inhibitor for the treatment of autoimmune diseases","volume":"58","author":"Farmer","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118642_bib40","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/nar\/gkx1210","article-title":"Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors","volume":"46","author":"Pflug","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.118642_bib41","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1021\/acs.jmedchem.0c01952","article-title":"Structural insights into JAK2 inhibition by ruxolitinib, fedratinib, and derivatives thereof","volume":"64","author":"Davis","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118642_bib42","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3390\/molecules28041849","article-title":"Design, synthesis, biological evaluation, and molecular dynamics simulation of influenza polymerase PB2 inhibitors","volume":"28","author":"Li","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118642_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejmech.2018.11.015","article-title":"Design, synthesis and biological evaluation of novel, orally bioavailable pyrimidine-fused heterocycles as influenza PB2 inhibitors","volume":"162","author":"Xiong","year":"2019","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:10:23Z","timestamp":1777529423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":43,"alternative-id":["S0223523426000875"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118642","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design of dual PB2\/JAK2 inhibitors achieving balanced antiviral and host-directed immunomodulatory effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118642"}}